NVL 1
Alternative Names: NVL-1; Positron emission tomography tracer - Neurovation LabsLatest Information Update: 30 Jun 2022
At a glance
- Originator Neurovation Labs
- Class Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Post-traumatic stress disorders
Most Recent Events
- 21 Jun 2022 Neurovation Labs receives SBIR grant from Department of defense for development of candidates in Post-traumatic stress disorder
- 01 Mar 2022 Neurovation Labs has patents pending for NVL 1, prior to March 2022 (Neurovation Labs pipeline, March 2022)
- 01 Mar 2022 Preclinical trials in Post-traumatic stress disorders (Diagnosis) in USA (unspecified route), prior to March 2022 (Neurovation Labs pipeline, March 2022)